Ascendis Pharma has been granted a patent for a controlled-release parathyroid hormone compound, PTH(1-34), conjugated to branched polyethylene glycol. The invention aims to treat conditions that can be managed with PTH. GlobalData’s report on Ascendis Pharma gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Ascendis Pharma, Nanoparticle drug conjugates was a key innovation area identified from patents. Ascendis Pharma's grant share as of February 2024 was 44%. Grant share is based on the ratio of number of grants to total number of patents.
The granted patent (Publication Number: US11918628B2) discloses a parathyroid hormone (PTH) conjugate represented by a specific formula. The conjugate can be in the form of a pharmaceutical composition along with at least one excipient, with the composition having a pH range of 4-6. Additionally, a liquid pharmaceutical composition containing the PTH conjugate is also claimed, with the solvent being water in this case.
The patent further specifies that the PTH conjugate or its pharmaceutically acceptable salt should have a specific moiety, with the integer values of 'm' and 'p' being the same. The liquid pharmaceutical composition containing the PTH conjugate should adhere to these criteria as well. Overall, the patent claims cover the specific PTH conjugate formula, its pharmaceutical compositions, and the liquid form of the composition, emphasizing the importance of the specific structure and conditions for the effectiveness of the conjugate in pharmaceutical applications.
To know more about GlobalData’s detailed insights on Ascendis Pharma, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
